NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 983,836 Value ($000) $1,564 Avg Close Range
Q4 2023
Shares 921,610 Value ($000) $792 Avg Close Range
Q3 2023
Shares 886,901 Value ($000) $949 Avg Close Range
Q2 2023
Shares 850,956 Value ($000) $2,204 Avg Close Range
Q1 2023
Shares 790,837 Value ($000) $3,227 Avg Close Range
Q4 2022
Shares 748,724 Value ($000) $4 Avg Close Range
Q3 2022
Shares 737,316 Value ($000) $9,644 Avg Close Range
Q2 2022
Shares 728,614 Value ($000) $9,340 Avg Close Range
Q1 2022
Shares 702,314 Value ($000) $10,710 Avg Close Range
Q4 2021
Shares 697,974 Value ($000) $12,361 Avg Close Range
Q3 2021
Shares 643,873 Value ($000) $13,534 Avg Close Range
Q2 2021
Shares 575,796 Value ($000) $11,354 Avg Close Range
Q1 2021
Shares 458,313 Value ($000) $13,323 Avg Close Range
Q4 2020
Shares 345,517 Value ($000) $10,467 Avg Close Range
Q3 2020
Shares 301,259 Value ($000) $4,793 Avg Close Range
Q2 2020
Shares 244,380 Value ($000) $4,824 Avg Close Range
Q1 2020
Shares 234,788 Value ($000) $2,894 Avg Close Range
Q4 2019
Shares 187,091 Value ($000) $3,459 Avg Close Range
Q3 2019
Shares 94,431 Value ($000) $1,307 Avg Close Range
Q2 2019
Shares 99,181 Value ($000) $1,452 Avg Close Range